Pfizer Signs Deal To Manufacture And Supply Gilead’s Remdesivir For COVID-19 Treatment

The US drugmaker would provide contract manufacturing services at its facility in Kansas to produce the drug.

Pfizer Inc said on Friday it signed a multi-year agreement with Gilead Sciences Inc to manufacture and supply the company’s antiviral drug remdesivir for COVID-19 patients.

The US drugmaker would provide contract manufacturing services at its facility in Kansas to produce the drug.

Source: https://www.moneycontrol.com/news/trends/health-trends/pfizer-signs-deal-to-manufacture-and-supply-gileads-remdesivir-for-covid-19-treatment-5661431.html